PHASE II STUDY OF RECEPTORENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185HER2/NEU MONOCLONAL ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PEGRAM M.D.; LIPTON A.; HAYES D.F.; WEBER B.L.; BASELGA J.M.; TRIPATHY D.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF CLINICAL ONCOLOGY Year:1998 | Volume:16 | Issue:8 Page(s): 2659-2671

Download Full-Text

View:

114

Download:

Cites:

Information Journal Paper

Title

PHASE II STUDY OF RECEPTORENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185HER2/NEU MONOCLONAL ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT

Author(s)

Keywords

Not Registered.

Abstract

Cites

APPLICATION OF GENOMICS AND PROTEOMICS TECHNOLOGIES TO EARLY DIAGNOSIS OF REPRODUCTIVE ORGAN CANCERS

References

No record.

Cite

APA: Copy

PEGRAM, M.D., LIPTON, A., HAYES, D.F., WEBER, B.L., BASELGA, J.M., & TRIPATHY, D.. (1998). PHASE II STUDY OF RECEPTORENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185HER2/NEU MONOCLONAL ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT. JOURNAL OF CLINICAL ONCOLOGY, 16(8), 2659-2671. SID. https://sid.ir/paper/557101/en

Vancouver: Copy

PEGRAM M.D., LIPTON A., HAYES D.F., WEBER B.L., BASELGA J.M., TRIPATHY D.. PHASE II STUDY OF RECEPTORENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185HER2/NEU MONOCLONAL ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 1998;16(8):2659-2671. Available from: https://sid.ir/paper/557101/en

IEEE: Copy

M.D. PEGRAM, A. LIPTON, D.F. HAYES, B.L. WEBER, J.M. BASELGA, and D. TRIPATHY, “PHASE II STUDY OF RECEPTORENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185HER2/NEU MONOCLONAL ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT,” JOURNAL OF CLINICAL ONCOLOGY, vol. 16, no. 8, pp. 2659–2671, 1998, [Online]. Available: https://sid.ir/paper/557101/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops